DOCSLIB.ORG

Mail Order Maintenance Medication Exclusion List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mail Order Maintenance Medication Exclusion List Maintenance Medication Exclusion List The following is a list of drugs that are excluded as maintenance medications. Medications which are listed here cannot be filled through the mail order pharmacy for the mail order incentive. This list includes both formulary/preferred and non-formulary/non-preferred medications, and does not provide information regarding the specific coverage, limitations, exclusions or quotas an individual member may have. Some dosage forms and strengths of a particular drug may be considered maintenance medications, whereas others may not. This list is sorted alphabetically by generic drug name. Generic drug names are written in lower case letters. Brand drug names (or some generic drugs with a trade name) are written in CAPITAL letters. Some drugs do not have a brand name available, in such cases the generic name is listed in the “Brand Name” column. This list of drugs should not be used to determine pharmacy benefits, such as prescription copay/coinsurance amounts or formulary status. If you have questions about the formulary status of a medication, or your prescription benefits, please call our Member Services Department at 1-888-681-7878 (toll free). For the hearing or speech impaired: 1-800-521-4874 (toll free TTY). The medications on this list are subject to change at any time. Exclusions: Any formulation that is required to be administered by a skilled medical professional or in a medical office, drugs infused in the home or in an infusion center, drugs that may have other quantity restrictions, any state law that may prohibit the mailing of certain dosage formulation of a drug, drugs that have a high potential for waste and diversion, drugs that require temperature control upon mailing and drugs that require refrigeration. Kaiser Permanente Mail Order Pharmacy Maintenance Medication Exclusion List Generic Name Product Description abatacept ORENCIA INJ 125MG abatacept ORENCIA INJ 250MG/ML acetaminophen OFIRMEV INJ 10MG/ML acetaminophen (bulk) ACETAMINOPHEN POW acetaminophen w/ codeine acetaminophen/codeine #2 tab 300-15mg acetaminophen w/ codeine acetaminophen/codeine #3 tab 300-30mg acetaminophen w/ codeine acetaminophen/codeine #4 tab 300-60mg acetaminophen w/ codeine acetaminophen/codeine sol 120-12/5 acetaminophen w/ codeine CAPITAL/CODEINE SUS 120-12/5 acetaminophen w/ codeine COCET PLUS TAB 650-60MG acetaminophen w/ codeine COCET TAB 650-30MG acetaminophen-caff-dihydrocod acetaminophen/caffeine/dihydrocodeine bitart tab acetaminophen-caff-dihydrocod TREZIX CAP acetaminophen-isometheptene-caffeine MIGRALAM CAP acetaminophen-isometheptene-caffeine PRODRIN TAB acetaminophen-isometheptene-dichloralphenazone MIDRIN CAP acetaminophen-mag salicylate-phenyltolox-caffeine cafgesic forte tab acetaminophen-phenyltoloxamine-caffeine FLEXTRA CAP acetaminophen-salicylamide FRENADOL TAB acetaminophen-salicylamide-phenyltoloxamine ANABAR TAB acetaminophen-salicylamide-phenyltoloxamine dolorex cap acetaminophen-salicylamide-phenyltoloxamine duraxin cap acetaminophen-salicylamide-phenyltoloxamine-caffeine cafgesic cap acetanilide ACETANILIDE POW acrivastine-pseudoephedrine SEMPREX-D CAP 8-60MG adalimumab HUMIRA KIT 20MG/0.4 adalimumab HUMIRA KIT 40MG/0.8 adalimumab HUMIRA PEN KIT 40MG/0.8 alfentanil alfentanil inj 500/ml almotriptan malate AXERT TAB 12.5MG almotriptan malate AXERT TAB 6.25MG alprazolam alprazolam er tab 0.5mg er alprazolam alprazolam er tab 1mg er alprazolam alprazolam er tab 2mg er alprazolam alprazolam er tab 3mg er alprazolam ALPRAZOLAM INTENSOL CON 1 MG/ML alprazolam alprazolam odt tab 0.25mg alprazolam alprazolam odt tab 0.5mg od alprazolam alprazolam odt tab 1mg odt alprazolam alprazolam odt tab 2mg odt alprazolam alprazolam tab 0.25mg alprazolam alprazolam tab 0.5mg alprazolam alprazolam tab 1mg alprazolam alprazolam tab 2mg alprazolam-dietary management product GABAZOLAMINE PAK amobarbital sodium AMYTAL SODIUM INJ 500MG amphetamine-dextroamphetamine ADDERALL TAB 12.5MG amphetamine-dextroamphetamine ADDERALL TAB 15MG amphetamine-dextroamphetamine ADDERALL TAB 7.5MG amphetamine-dextroamphetamine ADDERALL XR CAP 10MG amphetamine-dextroamphetamine ADDERALL XR CAP 15MG amphetamine-dextroamphetamine ADDERALL XR CAP 20MG amphetamine-dextroamphetamine ADDERALL XR CAP 25MG amphetamine-dextroamphetamine ADDERALL XR CAP 30MG amphetamine-dextroamphetamine ADDERALL XR CAP 5MG Medications listed are not considered 'Maintenance Drugs' and cannot be provided under the mail order incentive. Revision date: January 2014 (ver v2 20140127) Page 2 of 24 Kaiser Permanente Mail Order Pharmacy Maintenance Medication Exclusion List Generic Name Product Description amphetamine-dextroamphetamine amphetamine/dextroamphetamine tab 10mg amphetamine-dextroamphetamine amphetamine/dextroamphetamine tab 20mg amphetamine-dextroamphetamine amphetamine/dextroamphetamine tab 30mg amphetamine-dextroamphetamine amphetamine/dextroamphetamine tab 5mg anakinra KINERET INJ armodafinil NUVIGIL TAB 150MG armodafinil NUVIGIL TAB 250MG armodafinil NUVIGIL TAB 50MG aspirin w/ codeine aspirin/codeine tab 325-30mg aspirin w/ codeine aspirin/codeine tab 325-60mg aspirin-acetaminophen-salicyl-caff LEVACET TAB benzonatate benzonatate cap 100mg benzonatate benzonatate cap 200mg benzonatate ZONATUSS CAP 150MG brompheniramine maleate BROMPHENIRAMINE MALEATE POW MALEATE brompheniramine maleate bromspiro liq 2mg/5ml brompheniramine maleate J-TAN PD DROP 1MG/ML brompheniramine maleate LODRANE 24 CAP brompheniramine maleate lohist-12 tab 12 hour brompheniramine maleate RESPA-BR TAB 11MG brompheniramine maleate-phenylephrine hcl tannate VAZOTAB CHW brompheniramine tannate BROVEX CT CHW 12MG brompheniramine tannate BROVEX SUS 12MG/5ML brompheniramine tannate J-TAN SUS brompheniramine tannate P-TEX SUS 10MG/5ML brompheniramine tannate TANACOF-XR SUS 8MG/5ML brompheniramine tannate-phenylephrine tannate brompheniramine tann/phenylephrine tann sus 4-5mg brompheniramine tannate-phenylephrine tannate brompheniramine/phenylephrine tannate sus tann brompheniramine tannate-phenylephrine tannate BROVEX ADT SUS 12-10 brompheniramine tannate-phenylephrine tannate C-TAN D PLUS SUS brompheniramine tannate-phenylephrine tannate J-TAN D SUS brompheniramine tannate-phenylephrine tannate RELHIST CHW brompheniramine tannate-phenylephrine tannate tanabid chw 2.2-1.58 brompheniramine tannate-pseudoephedrine tannate BROVEX PD SUS brompheniramine tannate-pseudoephedrine tannate LODRANE D SUS brompheniramine w/ dm-gg TRISPEC SFX LIQ brompheniramine w/ dm-gg TUSNEL CAP brompheniramine-diphenhydramine ALA-HIST TAB 6-25MG brompheniramine-diphenhydramine-phenylephrine ALA-HIST D TAB 6-25-20 brompheniramine-phenylephrine ALACOL DROP 0.4-1MG brompheniramine-phenylephrine ALACOL SYP 2-5MG brompheniramine-phenylephrine andehist nr syp 4-45mg/m brompheniramine-phenylephrine bpm pe liq brompheniramine-phenylephrine bpm pseudo tab 6-45mg brompheniramine-phenylephrine bromax d tab brompheniramine-phenylephrine bromfenex cap 12-120cr brompheniramine-phenylephrine bromhist pediatric drop brompheniramine-phenylephrine bromhist-nr drop brompheniramine-phenylephrine brompheniramine/pse cap 9-90mg brompheniramine-phenylephrine BROVEX PEB LIQ brompheniramine-phenylephrine BROVEX PSB LIQ brompheniramine-phenylephrine BROVEX PSE TAB 4-40MG brompheniramine-phenylephrine DECON-A ELX 2-5MG/5M brompheniramine-phenylephrine entre-b sus 6-10mg/5 brompheniramine-phenylephrine HISTEX SR TAB 10-120MG Medications listed are not considered 'Maintenance Drugs' and cannot be provided under the mail order incentive. Revision date: January 2014 (ver v2 20140127) Page 3 of 24 Kaiser Permanente Mail Order Pharmacy Maintenance Medication Exclusion List Generic Name Product Description brompheniramine-phenylephrine J-TAN D PD DROP 1-7.5MG brompheniramine-phenylephrine LODRANE 24D CAP 12-90MG brompheniramine-phenylephrine phenylephrine hcl/bromphenir mal cap 15-12mg brompheniramine-phenylephrine phenylephrine hcl/bromphenir mal cap 7.5-6mg brompheniramine-phenylephrine pse bpm liq brompheniramine-phenylephrine respahist cap 6-60mgcr brompheniramine-phenylephrine tanabid sr tab 6-30mg brompheniramine-phenylephrine vazotab tab brompheniramine-phenylephrine ZOTEX PE TAB bromphen-pseudoephed-chlorphen-phenyleph-methscopol SYMPAK II MIS buprenorphine BUTRANS DIS 10MCG/HR buprenorphine BUTRANS DIS 15MCG/HR buprenorphine BUTRANS DIS 20MCG/HR buprenorphine BUTRANS DIS 5MCG/HR buprenorphine hcl BUPRENEX INJ 0.3MG/ML buprenorphine hcl buprenorphine hcl inj 0.3mg/ml buprenorphine hcl buprenorphine hcl sub 2mg buprenorphine hcl buprenorphine hcl sub 8mg buprenorphine hcl (bulk) BUPRENORPHINE HCL POW HCL buprenorphine hcl-naloxone hcl dihydrate SUBOXONE MIS 12-3MG buprenorphine hcl-naloxone hcl dihydrate SUBOXONE MIS 2-0.5MG buprenorphine hcl-naloxone hcl dihydrate SUBOXONE MIS 4-1MG buprenorphine hcl-naloxone hcl dihydrate SUBOXONE MIS 8-2MG buprenorphine hcl-naloxone hcl dihydrate SUBOXONE SUB 2-0.5MG buprenorphine hcl-naloxone hcl dihydrate SUBOXONE SUB 8-2MG buprenorphine hcl-naloxone hcl dihydrate ZUBSOLV SUB 1.4-0.36 buprenorphine hcl-naloxone hcl dihydrate ZUBSOLV SUB 5.7-1.4 butabarbital sodium BUTISOL SODIUM ELX 30MG/5ML butabarbital sodium BUTISOL SODIUM TAB 30MG butabarbital sodium BUTISOL SODIUM TAB 50MG butalbital-acetaminophen butalbital/acetaminophen tab 50-325 butalbital-acetaminophen ORBIVAN CF TAB 50-300MG butalbital-acetaminophen PHRENILIN FORTE CAP FORTE butalbital-acetaminophen promacet tab 50-650mg butalbital-acetaminophen-caffeine ALAGESIC LQ SOL butalbital-acetaminophen-caffeine butalbital/acetaminophen/caffeine
Load more

Recommended publications
  • Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation
    www.sciencemag.org/cgi/content/full/327/5963/348/DC1 Supporting Online Material for Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation Jason Rihel,* David A. Prober, Anthony Arvanites, Kelvin Lam, Steven Zimmerman, Sumin Jang, Stephen J. Haggarty, David Kokel, Lee L. Rubin, Randall T. Peterson, Alexander F. Schier* *To whom correspondence should be addressed. E-mail: [email protected] (A.F.S.); [email protected] (J.R.) Published 15 January 2010, Science 327, 348 (2010) DOI: 10.1126/science.1183090 This PDF file includes: Materials and Methods SOM Text Figs. S1 to S18 Table S1 References Supporting Online Material Table of Contents Materials and Methods, pages 2-4 Supplemental Text 1-7, pages 5-10 Text 1. Psychotropic Drug Discovery, page 5 Text 2. Dose, pages 5-6 Text 3. Therapeutic Classes of Drugs Induce Correlated Behaviors, page 6 Text 4. Polypharmacology, pages 6-7 Text 5. Pharmacological Conservation, pages 7-9 Text 6. Non-overlapping Regulation of Rest/Wake States, page 9 Text 7. High Throughput Behavioral Screening in Practice, page 10 Supplemental Figure Legends, pages 11-14 Figure S1. Expanded hierarchical clustering analysis, pages 15-18 Figure S2. Hierarchical and k-means clustering yield similar cluster architectures, page 19 Figure S3. Expanded k-means clustergram, pages 20-23 Figure S4. Behavioral fingerprints are stable across a range of doses, page 24 Figure S5. Compounds that share biological targets have highly correlated behavioral fingerprints, page 25 Figure S6. Examples of compounds that share biological targets and/or structural similarity that give similar behavioral profiles, page 26 Figure S7.
    [Show full text]
  • Histamine Receptors
    Tocris Scientific Review Series Tocri-lu-2945 Histamine Receptors Iwan de Esch and Rob Leurs Introduction Leiden/Amsterdam Center for Drug Research (LACDR), Division Histamine is one of the aminergic neurotransmitters and plays of Medicinal Chemistry, Faculty of Sciences, Vrije Universiteit an important role in the regulation of several (patho)physiological Amsterdam, De Boelelaan 1083, 1081 HV, Amsterdam, The processes. In the mammalian brain histamine is synthesised in Netherlands restricted populations of neurons that are located in the tuberomammillary nucleus of the posterior hypothalamus.1 Dr. Iwan de Esch is an assistant professor and Prof. Rob Leurs is These neurons project diffusely to most cerebral areas and have full professor and head of the Division of Medicinal Chemistry of been implicated in several brain functions (e.g. sleep/ the Leiden/Amsterdam Center of Drug Research (LACDR), VU wakefulness, hormonal secretion, cardiovascular control, University Amsterdam, The Netherlands. Since the seventies, thermoregulation, food intake, and memory formation).2 In histamine receptor research has been one of the traditional peripheral tissues, histamine is stored in mast cells, eosinophils, themes of the division. Molecular understanding of ligand- basophils, enterochromaffin cells and probably also in some receptor interaction is obtained by combining pharmacology specific neurons. Mast cell histamine plays an important role in (signal transduction, proliferation), molecular biology, receptor the pathogenesis of various allergic conditions. After mast cell modelling and the synthesis and identification of new ligands. degranulation, release of histamine leads to various well-known symptoms of allergic conditions in the skin and the airway system. In 1937, Bovet and Staub discovered compounds that antagonise the effect of histamine on these allergic reactions.3 Ever since, there has been intense research devoted towards finding novel ligands with (anti-) histaminergic activity.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Medication Instructions for Allergy Patients
    MEDICATION INSTRUCTIONS FOR ALLERGY PATIENTS Drugs which contain antihistamine or have antihistaminic effects can result in negative reactions to skin testing. As a result, it may not be possible to properly interpret skin test results, and testing may have to be repeated at a later date. While this list is extensive, it is NOT all inclusive (particularly of the various brand names). Discontinue ALL antihistamines including the following medications seven (7) days prior to skin testing (unless longer time specified): Antihistamines – Generic name (Brand name(s)): Cetirizine (Zyrtec, Zyrtec-D) Hydroxyzine (Vistaril, Atarax) Desloratadine (Clarinex) Levocetirizine (Xyzal) Fexofenadine (Allegra, Allegra-D) Loratadine (Claritin, Claritin-D, Alavert) Diphenhydramine (Aleve PM, Benadryl, Bayer P.M., Benylin, Contac P.M., Doans P.M, Excedrin PM, Legatrin P.M.. Nytol, Tylenol Nighttime, Unisom, Zzzquil) Chlorpheniramine (Aller-Chlor, Allerest, Alka Seltzer Plus, Chlor-Trimeton, Comtrex, Contac, Co-Pyronil, Coricidin, CTM, Deconamine, Dristan, Dura-tap, Naldecon, Ornade Spansules, Rondec, Sinutab, Teldrin, Triaminic, Triaminicin, Tylenol Allergy) Azatadine (Optimine, Trinalin) Doxylamine (Nyquil) Brompheniramine (Bromfed, Dimetane, Dimetapp) Meclizine (Antivert) Carbinoxamine (Clistin, Rondec) Pheniramine Clemastine (Tavist) Phenyltoloxamine (Nadecon) Cyclizine (Marezine) Promethazine (Phenergan) Cyprohepatidine (Periactin) (9 days) Pyrilamine (Mepyramine) Dexbrompheniramine (Drixoral) Quinacrine (Atabrine) Dexchlorpheniramine (Extendryl, Polaramine)
    [Show full text]
  • Prohibited Substances List
    Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR). Neither the List nor the EADCM Regulations are in current usage. Both come into effect on 1 January 2010. The current list of FEI prohibited substances remains in effect until 31 December 2009 and can be found at Annex II Vet Regs (11th edition) Changes in this List : Shaded row means that either removed or allowed at certain limits only SUBSTANCE ACTIVITY Banned Substances 1 Acebutolol Beta blocker 2 Acefylline Bronchodilator 3 Acemetacin NSAID 4 Acenocoumarol Anticoagulant 5 Acetanilid Analgesic/anti-pyretic 6 Acetohexamide Pancreatic stimulant 7 Acetominophen (Paracetamol) Analgesic/anti-pyretic 8 Acetophenazine Antipsychotic 9 Acetylmorphine Narcotic 10 Adinazolam Anxiolytic 11 Adiphenine Anti-spasmodic 12 Adrafinil Stimulant 13 Adrenaline Stimulant 14 Adrenochrome Haemostatic 15 Alclofenac NSAID 16 Alcuronium Muscle relaxant 17 Aldosterone Hormone 18 Alfentanil Narcotic 19 Allopurinol Xanthine oxidase inhibitor (anti-hyperuricaemia) 20 Almotriptan 5 HT agonist (anti-migraine) 21 Alphadolone acetate Neurosteriod 22 Alphaprodine Opiod analgesic 23 Alpidem Anxiolytic 24 Alprazolam Anxiolytic 25 Alprenolol Beta blocker 26 Althesin IV anaesthetic 27 Althiazide Diuretic 28 Altrenogest (in males and gelidngs) Oestrus suppression 29 Alverine Antispasmodic 30 Amantadine Dopaminergic 31 Ambenonium Cholinesterase inhibition 32 Ambucetamide Antispasmodic 33 Amethocaine Local anaesthetic 34 Amfepramone Stimulant 35 Amfetaminil Stimulant 36 Amidephrine Vasoconstrictor 37 Amiloride Diuretic 1 Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR).
    [Show full text]
  • Trends in Prescription Medication Use Among Children and Adolescents— United States, 1999-2014
    Supplementary Online Content Hales CM, Kit BK, Gu Q, Ogden CL. Trends in prescription medication use among children and adolescents— United States, 1999-2014. JAMA. doi:10.1001/jama.2018.5690 eTable. Classification of Prescription Medications Reported by NHANES Participants Aged 0-19 Years From 1999- 2000 to 2013-2014 by Therapeutic Class This supplementary material was provided by the authors to give readers additional informtion about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/27/2021 eTable. Classification of Prescription Medications Reported by NHANES Participants Aged 0-19 Years From 1999- 2000 to 2013-2014 by Therapeutic Class Therapeutic classes are based on the Lexicon Plus prescription medication database and only those classes reported in the manuscript are listed. ADHD Medications Antiadrenergic Agents, Centrally Acting Clonidine Guanfacine CNS Stimulants Amphetamines Amphetamine Amphetamine; Dextroamphetamine Dextroamphetamine Lisdexamfetamine Methylphenidate or Dexmethylphenidate Dexmethylphenidate Methylphenidate Other CNS Stimulant Pemoline Selective Norepinephrine Reuptake Inhibitor Atomoxetine Antibiotics Cephalosporins Cefadroxil Cephalexin Cefaclor Cefprozil Cefuroxime Loracarbef Cefdinir Cefditoren Cefixime Cefpodoxime Ceftibuten Ceftriaxone Glycopeptide Antibiotics Vancomycin H. Pylori Eradication Agents Amoxicillin; Clarithromycin; Lansoprazole Lincomycin Derivatives Clindamycin Macrolide Derivatives Telithromycin Azithromycin Clarithromycin
    [Show full text]
  • Bond Elut Certify Methods Manual
    AGILENT BOND ELUT CERTIFY AND CERTIFY II METHODS MANUAL TABLE OF CONTENTS INTRODUCTION AND OVERVIEW OF THE MANUAL .................................3 M2724 Meperidine (Pethidine) in Urine by GC or GC/MS ........................... 49 SUMMARY OF BOND ELUT CERTIFY AND CERTIFY II M2725 Methadone in Urine by GC or GC/MS ............................................. 50 MIXED MODE EXTRACTION ............................................................................5 M2726 Methaqualone in Urine by GC or GC/MS ........................................ 51 METHOD OPTIMIZATION .................................................................................6 M2727A 6-Monoacetyl Morphine in Urine by GC or GC/MS ........................ 52 PART NUMBERS................................................................................................8 M2727B 6-Monoacetyl Morphine in Urine by LC or LC/MS ......................... 53 SOLVENTS, SOLVENT MIXTURES, REAGENTS, AND SOLUTIONS .............................................................................................11 M2728 Nicotine in Urine by GC or GC/MS ................................................... 54 EQUIPMENT AND ACCESSORIES ................................................................17 M2729 Opiates (Free/Unbound) in Serum, Plasma, or Whole Blood by GC or GC/MS....................................... 55 BOND ELUT CERTIFY EXTRACTION METHODS ........................................ 29 M2730A Opiates in Urine by GC or GC/MS .................................................... 56 M2707A
    [Show full text]
  • FR-1973-03-19.Pdf
    MONDAY, MARCH 19, WASHINGTON, D.C. Volume 38 ■ Number 52 Pages 7205-7308 HIGHLIGHTS OF THIS ISSUE This listing does not affect the legal status of any document published in this issue. Detailed table of contents appears inside. PRESIDENTIAL DETERMINATION— Eligibility for the pur­ chase of defense articles under the Foreign Military Sales Act .......................... ........ ............................... — ........ ............ 7211 CONFIDENTIAL MEDICAL INFORMATION— HEW proposal on disclosure with consent of claimant and physician; comments by 4 -1 8 -7 3 ............................................................ 7239 MEDICARE— HEW rule on public disclosure; effective 3 -19-73 ................. .................................................................. 7221 DRUGS— FDA amendments and withdrawal of applications (9 documents).................................................................. 7264-7270 SEARCH WARRANTS— Justice Dept, list of persons authorized to request issuance...... .................................. 7244 RURAL ELECTRIFICATION LOANS— REA proposal on financing; comments by 4 -1 6 -7 3 .......................................... 7235 AIR/SEA CRUISE TOURS— CAB rule allows ship accomo­ dation to fulfill hotel requirement; effective 3 -1 3 -7 3 ........ 7219 EMPLOYMENT TAXES— IRS proposal on elective social security coverage for vow-of-poverty members of religious orders; comments by 4—8 -73.......-...................................... 7230 OCCUPATIONAL SAFETY AND HEALTH— OSHA proposal for review of State plans;
    [Show full text]
  • Anticholinergic Pocket Reference Card
    Anticholinergic Pocket Reference Card Because so many drugs have anticholinergic properties—and many of these are contained in over-the-counter products—anticholinergics are used by many older adults, including about 1/3 of people with dementia.1,2 The elderly are more sensitive to anticholinergic adverse effects, and people with dementia have a high risk of adverse cognitive and psychiatric effects from these drugs.3,4 Adverse effects attributed to anticholinergics include sedation, confusion, delirium, constipation, urinary retention, dry mouth, dry eyes, blurred vision, photophobia, tachycardia, decreased sweating, increased body temperature, falls, and others.5 Some evidence suggests that anticholinergics contribute to behavioral disturbances and psychosis in dementia.3 The purpose of this reference card is to help clinicians reduce anticholinergic use by vulnerable elders, especially those with cognitive impairment. Tapering may be necessary to prevent withdrawal symptoms when discontinuing potent anticholinergics that have been used chronically.2 The following lists medications with known anticholinergic effects by therapeutic use. The list is not all-inclusive, but includes many commonly used anticholinergics. Clinicians might want to especially consider the risk benefit balance of tricyclic antidepressants, immediate-release oxybutynin, GI antispasmodics, and sedating antihistamines, as these drugs are not recommended for vulnerable elders if alternative treatments are available.7 Antihistamines / Allergy / Bladder Antispasmodics Cough
    [Show full text]
  • Supplementary Material a Gene Expression Signature Associated
    Supplementary Material A Gene Expression Signature Associated With Overall Survival in Patients With Hepatocellular Carcinoma Suggests a New Treatment Strategy Jean-Pierre Gillet, Jesper B. Andersen, James P. Madigan, Sudhir Varma, Rachel K. Bagni, Katie Powell, William E. Burgan, Chung-Pu Wu, Anna Maria Calcagno, Suresh V. Ambudkar, Snorri S. Thorgeirsson, Michael M. Gottesman Journal: Molecular Pharmacology Table S1: Compounds highlighted through the Connectivity Map tool Rank for Name of drug on Connectivity Map score - Number of Connectivity Map Probability of getting Proportion of other drugs Drug signature is drug, rated Connectivity Map similarity between the experiments used score normalized an enrichment this that share this same significant for what according to gene expression signature to compute mean using scores from high if there is no signature (smaller values percent of the "n" p-value of drug and the signature similarity random selections of connection between mean that the signature is experiments? used as input genes drug signature and very specific to this input signature particular drug) Rank C-map name Mean n Enrichment p Specificity Percent non-null 1 8-azaguanine 0.916 4 0.975 0 0 100 2 adiphenine -0.765 5 -0.909 0 0.0242 100 3 trichostatin A 0.485 182 0.306 0 0.7204 73 4 tanespimycin 0.474 62 0.297 0 0.3834 72 5 apigenin 0.851 4 0.937 0.00002 0.0234 100 6 0175029-0000 0.797 6 0.86 0.00002 0.0177 100 7 thiamphenicol -0.711 5 -0.903 0.00004 0 100 8 thioguanosine 0.821 4 0.902 0.0001 0.0177 100 9 viomycin -0.723
    [Show full text]
  • Hydrocodone and Phenyltoloxamine
    PATIENT & CAREGIVER EDUCATION Hydrocodone and Phenyltoloxamine This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. Brand Names: Canada Tussionex [DSC] Warning This drug has an opioid drug in it. Opioid drugs can put you at risk for addiction, abuse, and misuse. Misuse or abuse of this drug can lead to overdose and death. If you have questions, talk with your doctor. You will be watched closely to make sure you do not misuse, abuse, or become addicted to this drug. This drug has an opioid drug in it. Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana or other forms of cannabis, or prescription or OTC drugs that may cause drowsiness or slowed actions. This includes slow or troubled breathing and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. Benzodiazepines may be used to treat many health problems like anxiety, trouble sleeping, or seizures. If you have questions, talk with the doctor. Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs. Do not take with alcohol or products that have alcohol. Unsafe and sometimes Hydrocodone and Phenyltoloxamine 1/9 deadly effects may happen. Get medical help right away if you feel very sleepy, very dizzy, or if you pass out.
    [Show full text]
  • Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
    Lääkealan turvallisuus- ja kehittämiskeskuksen päätös N:o xxxx lääkeluettelosta Annettu Helsingissä xx päivänä maaliskuuta 2016 ————— Lääkealan turvallisuus- ja kehittämiskeskus on 10 päivänä huhtikuuta 1987 annetun lääke- lain (395/1987) 83 §:n nojalla päättänyt vahvistaa seuraavan lääkeluettelon: 1 § Lääkeaineet ovat valmisteessa suolamuodossa Luettelon tarkoitus teknisen käsiteltävyyden vuoksi. Lääkeaine ja sen suolamuoto ovat biologisesti samanarvoisia. Tämä päätös sisältää luettelon Suomessa lääk- Liitteen 1 A aineet ovat lääkeaineanalogeja ja keellisessä käytössä olevista aineista ja rohdoksis- prohormoneja. Kaikki liitteen 1 A aineet rinnaste- ta. Lääkeluettelo laaditaan ottaen huomioon lää- taan aina vaikutuksen perusteella ainoastaan lää- kelain 3 ja 5 §:n säännökset. kemääräyksellä toimitettaviin lääkkeisiin. Lääkkeellä tarkoitetaan valmistetta tai ainetta, jonka tarkoituksena on sisäisesti tai ulkoisesti 2 § käytettynä parantaa, lievittää tai ehkäistä sairautta Lääkkeitä ovat tai sen oireita ihmisessä tai eläimessä. Lääkkeeksi 1) tämän päätöksen liitteessä 1 luetellut aineet, katsotaan myös sisäisesti tai ulkoisesti käytettävä niiden suolat ja esterit; aine tai aineiden yhdistelmä, jota voidaan käyttää 2) rikoslain 44 luvun 16 §:n 1 momentissa tar- ihmisen tai eläimen elintoimintojen palauttami- koitetuista dopingaineista annetussa valtioneuvos- seksi, korjaamiseksi tai muuttamiseksi farmako- ton asetuksessa kulloinkin luetellut dopingaineet; logisen, immunologisen tai metabolisen vaikutuk- ja sen avulla taikka terveydentilan
    [Show full text]